All Pathways
Obstetrics & GynecologyEmergency

Eclampsia & Severe Preeclampsia Management (ACOG 2020)

Eclampsia & Severe Preeclampsia Management (ACOG 2020): ECLAMPSIA: Seizure in Pregnancy/Postpartum → Eclampsia: Immediate Actions → Magnesium Sulfate - ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    ECLAMPSIA: Seizure in Pregnancy/Postpartum

    New-onset tonic-clonic seizure in patient with preeclampsia or unexplained in pregnancy

    1. Action

      Eclampsia: Immediate Actions

      Protect patient, establish airway, give magnesium

      • Call for help - activate emergency response
      • Position patient on left side
      • Protect from injury - padded bed rails
      • Suction secretions, maintain airway
      • Apply oxygen via face mask
      • Establish IV access
      1. Action

        Magnesium Sulfate - Loading

        Immediate seizure control and prevention

        • Loading: MgSO4 4-6g IV over 15-20 minutes
        • If seizure recurs: additional 2g IV bolus
        • Maintenance: 1-2g/hour continuous IV infusion
        • Monitor: reflexes, respiratory rate, urine output
        • Keep calcium gluconate at bedside (antidote)
        1. Action

          Acute Blood Pressure Control

          Target: <160/110 mmHg within 30-60 minutes

          • FIRST LINE: Labetalol 20mg IV, then 40mg, then 80mg q10min (max 300mg)
          • OR Hydralazine 5-10mg IV q20min (max 20mg)
          • OR Nifedipine IR 10-20mg PO q20min (max 50mg in 1hr)
          • If refractory: Nicardipine or Esmolol infusion
          • Avoid precipitous drops - risk of placental hypoperfusion
          • Continuous fetal monitoring during treatment
          1. Decision

            Gestational Age Assessment

            Determine timing of delivery

            1. Action

              ≥34 weeks: Deliver

              Delivery indicated for severe preeclampsia at ≥34 weeks

              • Stabilize BP and initiate magnesium
              • Mode of delivery based on obstetric factors
              • Induction of labor appropriate if cervix favorable
              • Cesarean if urgent maternal/fetal indications
              • Continue magnesium through delivery and 24h postpartum
              1. Decision

                HELLP Syndrome Present?

                Hemolysis, Elevated Liver enzymes, Low Platelets

                • Hemolysis: LDH >600, schistocytes, bilirubin >1.2
                • Elevated liver enzymes: AST/ALT >2x normal
                • Low platelets: <100,000/μL
                1. Action

                  HELLP Syndrome Management

                  High-risk - delivery usually indicated

                  • Delivery is definitive treatment
                  • Platelet transfusion if <20K or <50K with bleeding/surgery
                  • Correct coagulopathy with FFP if needed
                  • Monitor for liver hematoma/rupture (RUQ pain)
                  • CT/MRI if suspect hepatic complications
                  • Dexamethasone controversial - limited evidence
                  1. Outcome

                    Patient Stabilized - Continued Care

                    Ongoing monitoring and supportive care

                2. Outcome

                  Postpartum Monitoring

                  Continue monitoring, gradual resolution expected

                  • Continue magnesium 24-48 hours postpartum
                  • BP monitoring every 4 hours
                  • Most patients improve within 48 hours
                  • May worsen initially postpartum - remain vigilant
                  • Antihypertensives for BP >150/100
                  • Counsel on recurrence risk (15-25% next pregnancy)
            2. Action

              <34 weeks: Stabilize & Consider Expectant

              Balance prematurity risks vs. disease progression

              • Betamethasone 12mg IM x2 doses, 24h apart
              • Stabilize BP and initiate magnesium
              • Expectant management at facility with maternal-fetal medicine
              • 24-48h for steroid benefit if stable
              • Serial labs: CBC, LFTs, Cr q6-12h
              • Continuous fetal monitoring
              1. Warning

                Indications for Immediate Delivery

                Do NOT delay for steroids

                • Uncontrolled severe hypertension despite maximum therapy
                • Eclampsia
                • Pulmonary edema
                • Placental abruption
                • DIC
                • Non-reassuring fetal status
                • Persistent severe symptoms despite treatment

Guideline Source

ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address chronic hypertension in pregnancy
  • Antihypertensive dosing may need institutional adjustment
  • HELLP syndrome requires additional specialized management
  • Does not address atypical preeclampsia presentations

Applicable Regions

USEUGlobal

UK: NICE guidelines may vary slightly on thresholds

US: Based on ACOG 2020 guidelines

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Eclampsia & Severe Preeclampsia Management (ACOG 2020)?

The Eclampsia & Severe Preeclampsia Management (ACOG 2020) is a emergency clinical algorithm for Obstetrics & Gynecology. It provides a structured decision tree to guide clinical decision-making, based on ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia.

What guideline is the Eclampsia & Severe Preeclampsia Management (ACOG 2020) based on?

This algorithm is based on ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia (DOI: 10.1097/AOG.0000000000003891).

What are the limitations of the Eclampsia & Severe Preeclampsia Management (ACOG 2020)?

Known limitations include: Does not address chronic hypertension in pregnancy; Antihypertensive dosing may need institutional adjustment; HELLP syndrome requires additional specialized management; Does not address atypical preeclampsia presentations. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Eclampsia & Severe Preeclampsia Management (ACOG 2020) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free